≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

Human immunodeficiency virus [HIV] disease resulting in other specified diseases, including avohilmo

Endpoint Browser

AB1_OTHER_DISEASE_WIDE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Primary healthcare outpatient: ICD-10 — B22
  • Hospital discharge: ICD-10 — B22
  • Cause of death: ICD-10 — B22

3 out of 7 registries used, show all original rules.

26

4. Check minimum number of events

None

26

5. Include endpoints

None

26

6. Filter based on genotype QC (FinnGen only)

21

Control definitions (FinnGen only)

Control exclude
AB1_HIV

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF5

Similar endpoints

↥

List of similar endpoints to Human immunodeficiency virus [HIV] disease resulting in other specified diseases, including avohilmo based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 21 5 16
Unadjusted period prevalence (%) 0.01 0.00 0.01
Median age at first event (years) 51.17 46.32 52.68

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
14
11
32.02
10.28
3.1
1.5
—
—
—
0
0
8
0
+∞
8.91
4.6
0.0
20.20
—
mg/mmol
—
8
0
15
25
16.37
7.95
4.9
1.4
—
—
—
0
0
9
11
12.86
5.16
6.3
1.5
—
—
—
0
0
15
59
5.80
3.81
20.7
5.3
—
—
—
0
0
10
24
6.72
3.79
1.3
1.3
—
—
—
0
0
9
24
5.59
3.11
1.7
1.4
—
—
—
0
0
14
61
4.53
2.95
17.0
7.0
—
—
—
0
0
13
56
4.20
2.69
4.4
3.0
—
—
estimate
—
0
0
8
23
4.85
2.58
1.9
5.3
1.63
1.72
%
—
8
23
17
97
4.29
2.48
22.1
7.4
1.99
1.77
e9/l
0.58
17
91
17
98
4.21
2.44
23.2
8.0
0.14
0.21
e9/l
1.66
17
89
16
89
3.90
2.24
25.9
13.2
0.00
0.00
e9/l
-0.00
16
72
15
87
3.26
1.91
24.7
6.1
0.82
0.69
%
0.57
15
82
16
96
3.43
1.90
23.4
7.3
0.04
0.04
e9/l
0.17
16
85
16
96
3.43
1.90
23.2
7.3
0.61
0.61
e9/l
0.00
16
86
11
52
3.23
1.82
8.0
3.5
—
—
—
0
0
6
19
3.93
1.80
3.0
12.2
—
—
—
0
0
13
72
2.95
1.73
3.1
3.3
129.54
182.23
ug/l
0.43
13
67
14
83
2.88
1.65
7.1
3.7
6.33
6.07
ph
—
6
48
14
83
2.88
1.65
2.6
2.0
1.54
1.55
mmol/l
0.02
14
65
8
34
3.11
1.49
1.4
1.7
—
—
—
0
0
14
86
2.72
1.41
3.8
9.7
1.22
1.21
mmol/l
0.27
14
76
16
109
2.71
1.35
26.7
14.9
3.19
4.53
e9/l
2.13
16
97
17
124
2.62
1.15
10.3
4.4
—
—
—
0
0
6
27
2.67
1.03
1.8
1.6
—
—
—
0
0
9
56
2.02
0.88
3.6
1.7
—
—
—
0
0
7
42
1.97
0.78
3.0
3.0
—
—
—
0
0
10
64
2.03
0.75
4.6
5.5
—
—
—
0
0
5
27
2.09
0.73
1.8
1.4
—
665.00
—
0
8
6
36
1.91
0.63
1.5
1.9
29.50
29.00
s
—
6
36
11
77
1.86
0.61
5.5
3.3
10.65
9.48
mmol/l
0.26
11
64
7
45
1.81
0.56
2.1
1.6
2.53
1.27
mg/l
—
7
39
0
15
0.00
0.43
0.0
1.1
—
—
—
0
0
0
17
0.00
0.42
0.0
1.5
—
6.13
—
0
12
5
41
1.28
0.24
1.4
1.2
—
35.24
—
0
16
0
12
0.00
0.22
0.0
1.7
—
—
—
0
0
0
13
0.00
0.21
0.0
4.2
—
4.82
—
0
13
8
70
1.22
0.19
5.1
1.9
132.63
133.32
u/l
—
8
65
7
61
1.22
0.09
2.6
2.8
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
0.79
—
0
7
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
8
82
0.96
-0.00
3.3
3.2
—
—
estimate
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
7.8
—
13.57
—
0
6
17
163
1.19
-0.00
43.9
22.1
332.47
332.62
g/l
0.03
17
163
0
6
0.00
-0.00
0.0
4.8
—
1.62
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
6.7
—
1.02
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.2
—
80.56
—
0
5
0
5
0.00
-0.00
0.0
2.2
—
23.24
—
0
5
0
5
0.00
-0.00
0.0
5.4
—
6.42
—
0
5
0
9
0.00
-0.00
0.0
5.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.5
—
348.75
—
0
8

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: AB1_OTHER_DISEASE_WIDE – Human immunodeficiency virus [HIV] disease resulting in other specified diseases, including avohilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).